Fibroblast Activation Protein Inhibitor Clinical Trials
2 recruiting trials for Fibroblast Activation Protein Inhibitor. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Fibroblast Activation Protein Inhibitor clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 2 is the largest group at 50% (1 studies); the largest phase groups are Phase 2: 1, Phase 2 / Phase 3: 1.
Research is led by Aalborg University Hospital (1), Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is [68Ga]Ga-FAPI-46 PET/CT (drug, 1 trial), followed by Fibroblast Activation Protein Inhibitor.
Track Fibroblast Activation Protein Inhibitor trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Seventy (N=70) patients with suspected pleural mesothelioma (PM) lesions referred to pleural biopsy will be recruited, and undergo an additional FAPI PET/CT at primary staging....
Unravelling Intestinal Fibrosis in Ulcerative Colitis
The main objectives are: (i) to identify candidate fibrotic cellular pathways in UC patients treated with a JAK inhibitor filgotinib), and (ii) to detect and monitor in vivo...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Fibroblast Activation Protein Inhibitor, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Fibroblast Activation Protein Inhibitor, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Fibroblast Activation Protein Inhibitor, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.